Rohto Pharmaceutical Co., Ltd. (4527) Press Release
Notice Regarding the Status of Repurchase of Shares
Earlier from Rohto Pharmaceutical
- Rohto Pharmaceutical: Notice Regarding Voluntary Recall of Vietnamese-Made Eye Drops in the United States
- Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2027 (Three Months Ended June 30, 2026)
- Fujitsu develops multi-AI agent collaboration technology to optimize supply chains, launches joint trials
- Waldencast plc strengthens balance sheet position with the announcement of a trademark sale for Japan and refinancing of its credit facilities